Delivery Order SPE2DB22D2005-SPE2DB25FJSF9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Phenazopyridine 200 mg tablets in quantities of 100 units, with a ceiling value of $2,130.14. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,662.56 to AmerisourceBergen Drug Corp for phenazopyridine hydrochloride on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $818.04 delivery order to Amerisourcebergen Drug Corporation for 200mg phenazopyridine tablets. Under the firm fixed price contract, Amerisourcebergen will deliver 100 count bottles of the medication to a location in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite delivery/indefinite quantity contract vehicle....
- The Defense Logistics Agency awarded a $166,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg phenazopyridine tablets. As the prime contractor, Amerisourcebergen will deliver 100 count bottles of the medication to a facility in Conshohocken, Pennsylvania under a one day period of performance beginning September 6, 2023. The Defense Logistics Agency is a combat support agency within the Department of Defense responsible for worldwide logistics support. This...
- The Defense Logistics Agency awarded a $171 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg phenazopyridine tablets. As the prime contractor, Amerisourcebergen will deliver 100 count bottles of the medication to a facility in Conshohocken, Pennsylvania between September 1st and 5th, 2023. The order was placed under an existing DLA contract vehicle but no additional details were provided. Amerisourcebergen Corporation will perform as the prime with no mention of...
- The Defense Logistics Agency awarded a delivery order valued at $822.08 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4562114311 Phenazopyridine 200 mg tablets packaged in quantities of 100 tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The firm fixed price order is for the delivery of the pharmaceutical product with performance required between September 11-12, 2023. As a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is a delivery order for 4,563,864,459 units of the pharmaceutical product Phenazopyridine 200 mg tablets, packaged in 100s. The contract has a firm fixed price of $1,440.00 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in...
- The Defense Logistics Agency awarded a $1,447.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 100 tablets of 100 milligram phenazopyridine. The place of performance is Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The period of performance is July 18, 2023 through July 19, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,572.37 firm-fixed-price delivery order is for the supply of 4,567,013,416 units of the drug PHENAZOPYRIDINE 200 MG TAB 100S. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.95 firm fixed price delivery order is for the supply of 100 tablets of Phenazopyridine 200 mg, a drug used to treat urinary tract infections. The contract has an ultimate completion date of January 28, 2025 and does not have a set-aside designation, indicating open competition....
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSF9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenazopyridine 100 mg tablets (100 count) under a firm fixed-price contract with a ceiling value of $1,628.32. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location, serving the federal government's pharmaceutical supply needs through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards covering a wide range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic domains. The company's qualifications to fulfill this order are demonstrated through its established capability to competitively meet federal procurement requirements and serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/20/25 |